Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Roadblocks to translational advances on metastasis research

Nature Medicine volume 19, pages 1104–1109 (2013)Cite this article

Subjects

Promising advances in cancer therapy stemming from an increasing understanding of the molecular and genetic underpinnings of the tumorigenic process have been fueled by a strong, determined scientific community, influential patient advocacy groups and committed funding bodies. Despite these efforts, the development of effective drugs to prevent systemic dissemination of cancer cells or to eliminate overt metastasis in secondary organs remains a challenge to both researchers and physicians. In an attempt to tackle the most relevant and timely translational issues, a meeting held in 2012 as a result of a successful partnership between the Volkswagen Foundation and Nature Medicine brought together a group of metastasis research experts to identify the most important hurdles and help create a framework for potential clinical and translational strategies.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Nguyen, D.X., Bos, P.D. & Massague, J. Nat. Rev. Cancer 9, 274–284 (2009).

    Article  CAS  Google Scholar 

  2. Fearon, E.R. & Vogelstein, B. Cell 61, 759–767 (1990).

    Article  CAS  Google Scholar 

  3. Brabletz, T. et al. Proc. Natl. Acad. Sci. USA 98, 10356–10361 (2001).

    Article  CAS  Google Scholar 

  4. Brabletz, T. Nat. Rev. Cancer 12, 425–436 (2012).

    Article  CAS  Google Scholar 

  5. Chaffer, C.L. & Weinberg, R.A. Science 331, 1559–1564 (2011).

    Article  CAS  Google Scholar 

  6. Dalerba, P., Cho, R.W. & Clarke, M.F. Annu. Rev. Med. 58, 267–284 (2007).

    Article  CAS  Google Scholar 

  7. Thiery, J.P., Acloque, H., Huang, R.Y. & Nieto, M.A. Cell 139, 871–890 (2009).

    Article  CAS  Google Scholar 

  8. Brabletz, T., Jung, A., Spaderna, S., Hlubek, F. & Kirchner, T. Nat. Rev. Cancer 5, 744–749 (2005).

    Article  CAS  Google Scholar 

  9. Mani, S.A. et al. Cell 133, 704–715 (2008).

    Article  CAS  Google Scholar 

  10. Pantel, K. & Alix-Panabières, C. Trends Mol. Med. 16, 398–406 (2010).

    Article  Google Scholar 

  11. Aguirre-Ghiso, J.A., Bragado, P. & Sosa, M.S. Nat. Med. 19, 276–277 (2013).

    Article  CAS  Google Scholar 

  12. Kreso, A. et al. Science 339, 543–548 (2013).

    Article  CAS  Google Scholar 

  13. Korpal, M. et al. Nat. Med. 17, 1101–1108 (2011).

    Article  CAS  Google Scholar 

  14. Ocaña, O.H. et al. Cancer Cell 22, 709–724 (2012).

    Article  Google Scholar 

  15. Tsai, J.H., Donaher, J.L. & Murphy, D.A. Cancer Cell 22, 725–736 (2012).

    Article  CAS  Google Scholar 

  16. Singh, A. & Settleman, J. Oncogene 29, 4741–4751 (2010).

    Article  CAS  Google Scholar 

  17. Stoecklein, N.H. et al. Cancer Cell 13, 441–453 (2008).

    Article  CAS  Google Scholar 

  18. Podsypanina, K. et al. Science 321, 1841–1844 (2008).

    Article  CAS  Google Scholar 

  19. Joosse, S.A. & Pantel, K. Cancer Res. 73, 8–11 (2013).

    Article  CAS  Google Scholar 

  20. Weiss, L. Adv. Cancer Res. 54, 159–211 (1990).

    Article  CAS  Google Scholar 

  21. Peinado, H., Lavotshkin, S. & Lyden, D. Semin. Cancer Biol. 21, 139–146 (2011).

    Article  CAS  Google Scholar 

  22. Kaplan, R.N. et al. Nature 438, 820–827 (2005).

    Article  CAS  Google Scholar 

  23. Crawford, Y. & Ferrara, N. Cell Tissue Res. 335, 261–269 (2009).

    Article  CAS  Google Scholar 

  24. Müller, A. et al. Nature 410, 50–56 (2001).

    Article  Google Scholar 

  25. Peinado, H. et al. Nat. Med. 18, 883–891 (2012).

    Article  CAS  Google Scholar 

  26. Psaila, B. & Lyden, D. Nat. Rev. Cancer 9, 285–293 (2009).

    Article  CAS  Google Scholar 

  27. Paget, S. Lancet 1, 571–573 (1889).

    Article  Google Scholar 

  28. Hanahan, D. & Coussens, L.M. Cancer Cell 21, 309–322 (2012).

    Article  CAS  Google Scholar 

  29. Valastyan, S. & Weinberg, R.A. Cell 147, 275–292 (2011).

    Article  CAS  Google Scholar 

  30. Rhim, A.D. et al. Cell 148, 349–361 (2012).

    Article  CAS  Google Scholar 

  31. Pantel, K. et al. Clin. Chem. 58, 936–940 (2012).

    Article  CAS  Google Scholar 

  32. Kang, Y. & Pantel, K. Cancer Cell 23, 573–581 (2013).

    Article  CAS  Google Scholar 

  33. Moserle, L. & Casanovas, O. J. Intern. Med. 273, 128–137 (2013).

    Article  CAS  Google Scholar 

  34. He, S. et al. J. Pathol. 227, 431–445 (2012).

    Article  CAS  Google Scholar 

  35. Chou, J. et al. Nat. Cell Biol. 15, 201–213 (2013).

    Article  CAS  Google Scholar 

  36. McMillin, D.W., Negri, J.M. & Mitsiades, C.S. Nat. Rev. Drug Discov. 12, 217–228 (2013).

    Article  CAS  Google Scholar 

  37. Levental, K.R. et al. Cell 139, 891–906 (2009).

    Article  CAS  Google Scholar 

  38. Erez, N., Truitt, M., Olson, P., Arron, S.T. & Hanahan, D. Cancer Cell 17, 135–147 (2010).

    Article  CAS  Google Scholar 

  39. Tan, W. et al. Nature 470, 548–553 (2011).

    Article  CAS  Google Scholar 

  40. Allinen, M. et al. Cancer Cell 6, 17–32 (2004).

    Article  CAS  Google Scholar 

  41. Loeffler, M., Kruger, J.A., Niethammer, A.G. & Reisfeld, R.A. J. Clin. Invest. 116, 1955–1962 (2006).

    Article  CAS  Google Scholar 

  42. Chen, Y. et al. J. Clin. Invest. 123, 2395–2407 (2013).

    Article  CAS  Google Scholar 

  43. Nakasone, E.S. et al. Cancer Cell 21, 488–503 (2012).

    Article  CAS  Google Scholar 

  44. Kelber, J.A. et al. Cancer Res. 72, 2554–2564 (2012).

    Article  CAS  Google Scholar 

  45. Acharyya, S. et al. Cell 150, 165–178 (2012).

    Article  CAS  Google Scholar 

  46. Hao, J. et al. PLoS ONE 7, e40716 (2012).

    Article  CAS  Google Scholar 

  47. Tenbaum, S.P. et al. Nat. Med. 18, 892–901 (2012).

    Article  CAS  Google Scholar 

  48. Houthuijzen, J.M., Daenen, L., Roodhart, J. & Voest, E. Br. J. Cancer 106, 1901–1906 (2012).

    Article  CAS  Google Scholar 

  49. Liu, S., Tetzlaff, M., Cui, R. & Xu, X. Am. J. Pathol. 181, 1823–1835 (2012).

    Article  CAS  Google Scholar 

  50. Li, P., Lin, Y., Zhang, Y., Zhu, Z. & Huo, K. J. Transl. Med. 11, 52 (2013).

    Article  Google Scholar 

  51. Guerin, E., Man, S., Xu, P. & Kerbel, R. Cancer Res. 73, 2743–2748 (2013).

    Article  CAS  Google Scholar 

  52. Ding, Z. et al. Cell 148, 896–907 (2012).

    Article  CAS  Google Scholar 

  53. Morton, J.P. et al. Gastroenterology 139, 292–303 (2010).

    Article  CAS  Google Scholar 

  54. Marshall, J.C. et al. J. Natl. Cancer Inst. 104, 1306–1319 (2012).

    Article  CAS  Google Scholar 

  55. Palmieri, D. et al. Clin. Cancer Res. 15, 6148–6157 (2009).

    Article  CAS  Google Scholar 

  56. Kishida, Y., Yoshikawa, H. & Myoui, A. Clin. Cancer Res. 13, 59–67 (2007).

    Article  CAS  Google Scholar 

  57. LoRusso, P.M. et al. Clin. Cancer Res. 18, 6101–6109 (2012).

    Article  Google Scholar 

  58. Steeg, P.S. Nature 485, S58–S59 (2012).

    Article  CAS  Google Scholar 

  59. Palmieri, D. et al. Cancer Res. 67, 4190–4198 (2007).

    Article  CAS  Google Scholar 

  60. Stemmler, H.-J. et al. Anticancer Drugs 18, 23–28 (2007).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

T.B. is supported by the Deutsche Forschungsgemeinschaft (SFB850, B2 and SFB992, C06) and the Deutsche Krebshilfe (grant 109430).

Author information

Author notes

  1. Thomas Brabletz, David Lyden, Patricia S Steeg and Zena Werb: All authors contributed equally to this work.

Authors and Affiliations

  1. Thomas Brabletz is at the Department of General and Visceral Surgery, Comprehensive Cancer Center and BIOSS Centre for Biological Signalling Studies, University of Freiburg Medical Center, Freiburg, Germany.,

    Thomas Brabletz

  2. David Lyden is at the Department of Pediatrics and the Department of Cell and Developmental Biology, Weill Cornell Medical College and Memorial Sloan-Kettering Cancer Center, New York, New York, USA.,

    David Lyden

  3. Patricia S. Steeg is in the Women's Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, US National Cancer Institute, Bethesda, Maryland, USA.,

    Patricia S Steeg

  4. Zena Werb is at the Department of Anatomy, University of California, San Francisco, San Francisco, California, USA.,

    Zena Werb

Authors
  1. Thomas Brabletz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Lyden
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patricia S Steeg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zena Werb
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Thomas Brabletz, David Lyden, Patricia S Steeg or Zena Werb.

Ethics declarations

Competing interests

P.S.S. receives research funding from Sanofi. The other authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brabletz, T., Lyden, D., Steeg, P. et al. Roadblocks to translational advances on metastasis research. Nat Med 19, 1104–1109 (2013). https://doi.org/10.1038/nm.3327

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.3327

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer